Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flows from Operating Activities:
Net income	$ 9,841	$ 9,434
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,957	1,719
Deferred income tax provision/ (benefit)- net	575	(800)
Provision for bad debts	(1,140)	(194)
Stock issued for costs and expenses		2,239
Compensatory element of stock issuances		$ 27
Stock option exercised		2
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(1,492)	$ (2,701)
Notes receivable		12
Inventories	(71)	(661)
Prepaid expenses and other current assets	(74)	(178)
Other assets	(150)	172
Increase (decrease) in operating liabilities, net:
Accounts payable	(58)	216
Other current liabilities	(608)	(2,590)
Customer advances	110	(163)
Billings in excess of costs and estimated earnings on completed contracts		(30)
Other liabilities	(10)	170
Due to related medical practices		(17)
Net cash provided by operating activities	8,880	6,657
Cash Flows from Investing Activities:
Purchases of property and equipment	(1,862)	(1,507)
Cost of patents	(51)	(96)
Net cash used in investing activities	(1,913)	(1,603)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(99)	(2,422)
Additional Acquisition Costs	(58)
Distributions to noncontrolling interests	(2,760)	(3,472)
Repayment of notes receivable from employee stockholders	4	4
Net cash used in financing activities	(2,913)	(5,890)
Net (Decrease) Increase in Cash and Cash Equivalents	4,054	(836)
Cash and Cash Equivalents - Beginning of Period	10,140	8,528
Cash and Cash Equivalents - End of Period	$ 14,194	$ 7,692